These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 12649149)

  • 61. CD28 function: a balance of costimulatory and regulatory signals.
    Bour-Jordan H; Blueston JA
    J Clin Immunol; 2002 Jan; 22(1):1-7. PubMed ID: 11958588
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CTLA-4 is required for the induction of high dose oral tolerance.
    Samoilova EB; Horton JL; Zhang H; Khoury SJ; Weiner HL; Chen Y
    Int Immunol; 1998 Apr; 10(4):491-8. PubMed ID: 9620605
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Costimulation blockade promotes the apoptotic death of graft-infiltrating T cells and prolongs survival of hepatic allografts from FLT3L-treated donors.
    Li W; Lu L; Wang Z; Wang L; Fung JJ; Thomson AW; Qian S
    Transplantation; 2001 Oct; 72(8):1423-32. PubMed ID: 11685115
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation.
    Freeman GJ; Gribben JG; Boussiotis VA; Ng JW; Restivo VA; Lombard LA; Gray GS; Nadler LM
    Science; 1993 Nov; 262(5135):909-11. PubMed ID: 7694363
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Negative effect of CTLA-4 on induction of T-cell immunity in vivo to B7-1+, but not B7-2+, murine myelogenous leukemia.
    LaBelle JL; Hanke CA; Blazar BR; Truitt RL
    Blood; 2002 Mar; 99(6):2146-53. PubMed ID: 11877291
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
    Krummel MF; Allison JP
    J Exp Med; 1995 Aug; 182(2):459-65. PubMed ID: 7543139
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhancement of antitumor immunity by CTLA-4 blockade.
    Leach DR; Krummel MF; Allison JP
    Science; 1996 Mar; 271(5256):1734-6. PubMed ID: 8596936
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term survival of rat to mouse cardiac xenografts with prolonged blockade of CD28-B7 interaction combined with peritransplant T-cell depletion.
    Rehman A; Tu Y; Arima T; Linsley PS; Flye MW
    Surgery; 1996 Aug; 120(2):205-12. PubMed ID: 8751584
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antagonist properties of monoclonal antibodies targeting human CD28: role of valency and the heavy-chain constant domain.
    Mary C; Coulon F; Poirier N; Dilek N; Martinet B; Blancho G; Vanhove B
    MAbs; 2013; 5(1):47-55. PubMed ID: 23221503
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies.
    Murata K; Dalakas MC
    Am J Pathol; 1999 Aug; 155(2):453-60. PubMed ID: 10433938
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Costimulation and its role in organ transplantation.
    Bluestone JA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):104-9. PubMed ID: 8680045
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.
    Li J; Semple K; Suh WK; Liu C; Chen F; Blazar BR; Yu XZ
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):962-9. PubMed ID: 21447398
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
    Kim KS; Denton MD; Chandraker A; Knoflach A; Milord R; Waaga AM; Turka LA; Russell ME; Peach R; Sayegh MH
    Am J Pathol; 2001 Mar; 158(3):977-86. PubMed ID: 11238045
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice.
    Villegas EN; Wille U; Craig L; Linsley PS; Rennick DM; Peach R; Hunter CA
    Infect Immun; 2000 May; 68(5):2837-44. PubMed ID: 10768980
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.
    Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ
    Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138
    [TBL] [Abstract][Full Text] [Related]  

  • 76. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.
    Caux C; Vanbervliet B; Massacrier C; Azuma M; Okumura K; Lanier LL; Banchereau J
    J Exp Med; 1994 Nov; 180(5):1841-7. PubMed ID: 7525840
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway.
    Ndejembi MP; Teijaro JR; Patke DS; Bingaman AW; Chandok MR; Azimzadeh A; Nadler SG; Farber DL
    J Immunol; 2006 Dec; 177(11):7698-706. PubMed ID: 17114440
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Targeting CD28, CTLA-4 and PD-L1 costimulation differentially controls immune synapses and function of human regulatory and conventional T-cells.
    Dilek N; Poirier N; Hulin P; Coulon F; Mary C; Ville S; Vie H; Clémenceau B; Blancho G; Vanhove B
    PLoS One; 2013; 8(12):e83139. PubMed ID: 24376655
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
    Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
    Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Detection of a soluble form of B7-1 (CD80) in synovial fluid from patients with arthritis using monoclonal antibodies against distinct epitopes of human B7-1.
    McHugh RS; Ratnoff WD; Gilmartin R; Sell KW; Selvaraj P
    Clin Immunol Immunopathol; 1998 Apr; 87(1):50-9. PubMed ID: 9576010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.